
Shares of medtech company TransMedics Group TMDX.O rise 1.6% to $130.79
Piper Sandler raises TMDX's PT to $145 from $125
Piper believes TMDX is on track to beat sales estimates for Q2, which could continue stock's strong momentum seen in recent months
While there was a slight decline in plane volumes in May compared to April, brokerage believes TMDX continues to see strong adoption of its aviation services
TMDX still appears positioned to deliver sequential quarterly growth in its logistics business given May flight volumes were higher than each month in Q1 - Piper
TMDX up 106.5% YTD, as of last close